IL139059A0 - Hydroxamic acid derivates as antibacterials - Google Patents

Hydroxamic acid derivates as antibacterials

Info

Publication number
IL139059A0
IL139059A0 IL13905999A IL13905999A IL139059A0 IL 139059 A0 IL139059 A0 IL 139059A0 IL 13905999 A IL13905999 A IL 13905999A IL 13905999 A IL13905999 A IL 13905999A IL 139059 A0 IL139059 A0 IL 139059A0
Authority
IL
Israel
Prior art keywords
group
antibacterials
alkyl
independently
hydroxamic acid
Prior art date
Application number
IL13905999A
Other languages
English (en)
Original Assignee
British Biotech Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Biotech Pharm filed Critical British Biotech Pharm
Publication of IL139059A0 publication Critical patent/IL139059A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4453Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/4261,3-Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
IL13905999A 1998-05-16 1999-05-14 Hydroxamic acid derivates as antibacterials IL139059A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9810464.9A GB9810464D0 (en) 1998-05-16 1998-05-16 Hydroxamic acid derivatives
PCT/GB1999/001541 WO1999059568A1 (en) 1998-05-16 1999-05-14 Hydroxamic acid derivatives as antibacterials

Publications (1)

Publication Number Publication Date
IL139059A0 true IL139059A0 (en) 2001-11-25

Family

ID=10832125

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13905999A IL139059A0 (en) 1998-05-16 1999-05-14 Hydroxamic acid derivates as antibacterials
IL139059A IL139059A (en) 1998-05-16 2000-10-16 Use of a history of hydroxamic acid for the preparation of antibacterial drugs

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL139059A IL139059A (en) 1998-05-16 2000-10-16 Use of a history of hydroxamic acid for the preparation of antibacterial drugs

Country Status (23)

Country Link
US (3) US6441042B1 (https=)
EP (2) EP1079819B1 (https=)
JP (1) JP2002515427A (https=)
KR (1) KR100634089B1 (https=)
CN (1) CN1300210A (https=)
AT (1) ATE347356T1 (https=)
AU (1) AU754063B2 (https=)
BR (1) BR9910488A (https=)
CA (1) CA2332713C (https=)
CY (1) CY1106452T1 (https=)
DE (1) DE69934309T2 (https=)
DK (1) DK1079819T3 (https=)
ES (1) ES2278444T3 (https=)
GB (2) GB9810464D0 (https=)
HU (1) HUP0102290A3 (https=)
IL (2) IL139059A0 (https=)
NO (1) NO20005782L (https=)
NZ (1) NZ507560A (https=)
PL (1) PL344438A1 (https=)
PT (1) PT1079819E (https=)
TR (1) TR200003376T2 (https=)
WO (1) WO1999059568A1 (https=)
ZA (1) ZA200006131B (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2349884A (en) * 1998-02-07 2000-11-15 British Biotech Pharm Antibacterial agents
GB9810464D0 (en) * 1998-05-16 1998-07-15 British Biotech Pharm Hydroxamic acid derivatives
US6908911B1 (en) * 1999-08-10 2005-06-21 British Biotech Pharmaceuticals Limited Antibacterial agents
WO2001040198A2 (fr) * 1999-11-30 2001-06-07 Aventis Pharma S.A. Derives macrocycliques de l'acide hydroxamique et leur utilisation en tant qu'antimicrobiens
FR2801591B1 (fr) * 1999-11-30 2002-03-01 Aventis Pharma Sa Derives macrocycliques de l'acide hydroxamique, leur preparation et les compositions qui les contiennent
GB9929979D0 (en) * 1999-12-17 2000-02-09 Darwin Discovery Ltd Hydroxamic acid derivatives
EP1237862A1 (en) * 1999-12-17 2002-09-11 Versicor, Inc. Succinate compounds, compositions and methods of use and preparation
AU2002230385A1 (en) * 2000-09-25 2002-04-15 Questcor Pharmaceuticals, Inc. Peptide deformylase inhibitors
WO2002041886A1 (en) * 2000-11-23 2002-05-30 British Biotech Pharmaceuticals Ltd Ydroxamic acid or n-formyl hydroxylamine derivatives as inhibitors of bakterial polypeptide deformylase for treating microbial infections
EP1372692A4 (en) * 2001-03-19 2005-10-26 Sloan Kettering Inst Cancer ASYMMETRIC SYNTHESIS OF (S, S, R) - (-) - ACTINONE AND ITS ANALOG AND USES THEREOF
US20040267015A1 (en) * 2001-04-05 2004-12-30 Ajita Bhat Peptide deformylase inhibitors
GB0128943D0 (en) * 2001-12-04 2002-01-23 Novo Pharmaceuticals De Ltd Bacterial enzyme inhibitors
JP4190862B2 (ja) * 2001-12-18 2008-12-03 シャープ株式会社 表示装置およびその駆動方法
GB0208579D0 (en) * 2002-04-13 2002-05-22 British Biotech Pharm Antibacterial agents
DE10320453A1 (de) * 2003-05-08 2004-11-25 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Bioisostere von Actinonin
US8993641B2 (en) * 2007-11-29 2015-03-31 Innolex Investment Corporation Preservation of cosmetics, toiletry and pharmaceutical compositions
DE102011088962A1 (de) * 2011-12-19 2013-06-20 Beiersdorf Ag Wirkstoffkombinationen aus einer oder mehreren Carbonsäuren, insbesondereHydroxycarbonsäuren, und einer oder mehreren physiologisch unbedenklichen Hydroxamsäure sowie kosmetische oder dermatologische Zubereitungen, solcheWirkstoffkombinationen enthaltend
US10829440B2 (en) 2015-06-12 2020-11-10 Brown University Antibacterial compounds and methods of making and using same
US11653649B2 (en) 2017-06-29 2023-05-23 Kimberly-Clark Worldwide, Inc. Antimicrobial composition including a dihydroxamic acid and methods of inhibiting microbial growth utilizing the same
CN108672095A (zh) * 2018-05-04 2018-10-19 广东省资源综合利用研究所 γ-羟基烷基羟肟酸及其制备方法与应用
US11555010B2 (en) 2019-07-25 2023-01-17 Brown University Diamide antimicrobial agents

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1028921A (en) * 1962-01-23 1966-05-11 Ranjeet Bhagwan Singh New antibiotic
US4303662A (en) * 1980-11-24 1981-12-01 E. R. Squibb & Sons, Inc. Carboxyacyl, mercapto and acylmercapto derivatives of heterobicyclo compounds
JPH0670019B2 (ja) * 1989-07-21 1994-09-07 明治製菓株式会社 新抗生物質sf2197c物質およびその製造法
GB8919251D0 (en) * 1989-08-24 1989-10-04 British Bio Technology Compounds
JPH03157372A (ja) * 1989-11-13 1991-07-05 Yamanouchi Pharmaceut Co Ltd Yl―01869p物質及びその製造法
WO1992022523A2 (en) * 1991-06-14 1992-12-23 Research Corporation Technologies, Inc. Peptide derivatives of collagenase inhibitor
GB9223904D0 (en) * 1992-11-13 1993-01-06 British Bio Technology Inhibition of cytokine production
FI960803A7 (fi) 1993-08-23 1996-04-22 Immunex Corp TNF-alfa-sekreetion inhibiittoreita
JP3157372B2 (ja) 1993-11-29 2001-04-16 三洋電機株式会社 フィルタ
JPH10501806A (ja) * 1994-06-22 1998-02-17 ブリティッシュ バイオテック ファーマシューティカルズ リミテッド 金属タンパク質分解酵素阻害剤
US5532265A (en) 1994-11-30 1996-07-02 The Board Of Trustees Of The Leland Stanford Junior University Treatment of central nervous system inflammatory disease with matrix metalloprotease inhibitors
GB9507799D0 (en) 1995-04-18 1995-05-31 British Biotech Pharm Metalloproteinase inhibitors
US6281245B1 (en) * 1996-10-28 2001-08-28 Versicor, Inc. Methods for solid-phase synthesis of hydroxylamine compounds and derivatives, and combinatorial libraries thereof
AU5187698A (en) * 1996-12-06 1998-06-29 Cancerforskningsfondet Af 1989 Inhibition of invasive remodelling
ZA9711121B (en) * 1996-12-13 1998-06-23 Handelman Joseph H Reduction of hair growth.
GB2349884A (en) * 1998-02-07 2000-11-15 British Biotech Pharm Antibacterial agents
GB9810464D0 (en) * 1998-05-16 1998-07-15 British Biotech Pharm Hydroxamic acid derivatives

Also Published As

Publication number Publication date
EP1754477A2 (en) 2007-02-21
EP1754477A3 (en) 2007-03-14
NZ507560A (en) 2003-06-30
AU754063B2 (en) 2002-10-31
PL344438A1 (en) 2001-11-05
JP2002515427A (ja) 2002-05-28
NO20005782D0 (no) 2000-11-15
AU3942199A (en) 1999-12-06
GB9810464D0 (en) 1998-07-15
WO1999059568A1 (en) 1999-11-25
DE69934309T2 (de) 2007-07-05
US20060211732A1 (en) 2006-09-21
NO20005782L (no) 2001-01-15
IL139059A (en) 2006-12-31
GB2353708A (en) 2001-03-07
BR9910488A (pt) 2001-01-09
DE69934309D1 (de) 2007-01-18
US20020198241A1 (en) 2002-12-26
PT1079819E (pt) 2007-03-30
CY1106452T1 (el) 2011-10-12
EP1079819B1 (en) 2006-12-06
US6992190B2 (en) 2006-01-31
EP1079819A1 (en) 2001-03-07
HUP0102290A2 (hu) 2001-11-28
KR100634089B1 (ko) 2006-10-17
CN1300210A (zh) 2001-06-20
GB0024789D0 (en) 2000-11-22
CA2332713C (en) 2008-04-01
TR200003376T2 (tr) 2001-03-21
ES2278444T3 (es) 2007-08-01
US7323563B2 (en) 2008-01-29
CA2332713A1 (en) 1999-11-25
ZA200006131B (en) 2002-01-30
ATE347356T1 (de) 2006-12-15
HUP0102290A3 (en) 2001-12-28
US6441042B1 (en) 2002-08-27
DK1079819T3 (da) 2007-04-10
KR20010034861A (ko) 2001-04-25

Similar Documents

Publication Publication Date Title
IL139059A0 (en) Hydroxamic acid derivates as antibacterials
GB2349884A (en) Antibacterial agents
DK0804421T3 (da) 2-((Dihydro)pyrazolyl-3'-oxymethylen)-anilider som skadedyrsbekæmpelsesmidler og fungicider
AU2001276416A1 (en) Substituted triazolopyrid(az)ines as plant treatment agents (herbicides)
BR9809531A (pt) Composições herbicidas.
ES2110673T3 (es) N-azinil-n'-(het)arilsulfonil-ureas como herbicidas.
AU2001281954A1 (en) Heterocyclic substituted herbicidal sulphonic acid anilides
PL350769A1 (en) Substituted aniline compounds
AP2000001976A0 (en) Synergistic herbicidal compositions based on phosphorus-containing foliar herbicides imidazolinones and growth-promoting herbicides
ITMI20000440A0 (it) Forme solide orali a rilascio controllato contenenti mesalazina come principio attivo
IE802135L (en) Pyrazolobenzodiazepines
AU5879798A (en) Agents inhibiting progress of pterygium and postoperative recurrence of the same
AP9701140A0 (en) New hydroximic acid derivatives.
ES2059918T3 (es) Metazacloro monoclinico y procedimiento para su fabricacion.
EA199900888A1 (ru) Противоревматические средства
ATE253356T1 (de) N-formyl hydroxylamin derivate als antibakterielle mittel
BR9909029A (pt) Estabilização de poliisocianatos orgânicos
DE60006053D1 (de) 2-Aryloxy-4-methyl-6-pyrazol-1-yl-pyridine wirksam als Herbizide
EP1570837A4 (en) DENDRIT EXTENSION INHIBITOR FOR MELANOZYT AND SKIN PREPARATION FOR EXTERNAL USE, INCLUDING THAT SAME.
AU2002319169A1 (en) Substituted benzoylketones as herbicidal agents for use as plant treatment agent
AU1978700A (en) Coloring agents comprising manganese cations
DE69614508D1 (de) Thiol derivate mit metallopeptidase inhibierender aktivitat
CA2278553A1 (en) Phenylsulfonylureas, processes for their preparation, and their use as herbicides and plant growth regulators
BR9901206A (pt) Derivados de pirimidinona.
CO4650115A1 (es) Nuevos derivados del acido hidroximico para uso en la pro- teccion de las plantas

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees